#BEGIN_DRUGCARD DB02571

# AHFS_Codes:
Not Available

# ATC_Codes:
Not Available

# Absorption:
Not Available

# Biotransformation:
Not Available

# Brand_Mixtures:
Not Available

# Brand_Names:
Not Available

# CAS_Registry_Number:
Not Available

# ChEBI_ID:
17917

# Chemical_Formula:
C6H11NO3

# Chemical_IUPAC_Name:
(2S)-2-amino-6-oxohexanoic acid

# Chemical_Structure:
Not Available

# Creation_Date:
2005-06-13 07:24:05 -0600

# DPD_Drug_ID_Number:
Not Available

# Description:
Not Available

# Dosage_Forms:
Not Available

# Drug_Category:
Not Available

# Drug_Interactions:
Not Available

# Drug_Reference:
Not Available

# Drug_Type:
Experimental
Small Molecule

# Experimental_Caco2_Permeability:
Not Available

# Experimental_LogP_Hydrophobicity:
Not Available

# Experimental_Logs:
Not Available

# Experimental_Water_Solubility:
Not Available

# Food_Interactions:
Not Available

# GenBank_ID:
Not Available

# Generic_Name:
2-Amino-6-Oxo-Hexanoic Acid

# HET_ID:
DO2

# Half_Life:
Not Available

# InChI_Identifier:
InChI=1S/C6H11NO3/c7-5(6(9)10)3-1-2-4-8/h4-5H,1-3,7H2,(H,9,10)/t5-/m0/s1

# InChI_Key:
InChIKey=GFXYTQPNNXGICT-YFKPBYRVSA-N

# Indication:
Not Available

# KEGG_Compound_ID:
C04076

# KEGG_Drug_ID:
Not Available

# LIMS_Drug_ID:
2571

# Mechanism_Of_Action:
Not Available

# Melting_Point:
Not Available

# Molecular_Weight_Avg:
145.1564

# Molecular_Weight_Mono:
145.073893223

# Organisms_Affected:
Not Available

# PDB_Experimental_ID:
1DJP

# PDB_Homology_ID:
Not Available

# PDRhealth_Link:
Not Available

# Pathways:
Not Available

# PharmGKB_ID:
Not Available

# Pharmacology:
Not Available

# Predicted_LogP_Hydrophobicity:
-2.2

# Predicted_LogS:
-0.47

# Predicted_Water_Solubility:
4.94e+01 g/l

# Primary_Accession_No:
DB02571

# Protein_Binding:
Not Available

# PubChem_Compound_ID:
160603

# PubChem_Substance_ID:
46505195

# RxList_Link:
Not Available

# Salts:
Not Available

# Secondary_Accession_No:
EXPT01240

# Smiles_String_canonical:
Not Available

# Smiles_String_isomeric:
N[C@@H](CCCC=O)C(O)=O

# State:
solid

# Structure:
1

# SwissProt_ID:
Not Available

# SwissProt_Name:
Not Available

# Synonyms:
Not Available

# Synthesis_Reference:
Not Available

# Toxicity:
Not Available

# Update_Date:
2013-02-08 16:21:16 -0700

# Wikipedia_Link:
Not Available

# pKa_Isoelectric_Point:
Not Available

# Drug_Target_1_Cellular_Location:
Periplasm

# Drug_Target_1_Chromosome_Location:
Not Available

# Drug_Target_1_Drug_References:
17016423	Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.
17139284	Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.

# Drug_Target_1_Essentiality:
Non-Essential

# Drug_Target_1_GenAtlas_ID:
Not Available

# Drug_Target_1_GenBank_ID_Gene:
AE015451

# Drug_Target_1_GenBank_ID_Protein:
24984014

# Drug_Target_1_GeneCard_ID:
Not Available

# Drug_Target_1_Gene_Name:
ansB

# Drug_Target_1_Gene_Sequence:
>1089 bp
TCAGTACTCCCAGAAGATCCGCTGCAGCTCTTTGCTGTCCTGGGTCTTGGTCATCGCTAC
CATCGCCAGGATCCGCGCTTTTTGCGGGTTCAGGTCGTGAGCCACGACCCAGTCGTTCTT
GTCATCCGGCTGTTCGGCATTACGCAGTACGAAACCACCCTGGTTGACATGCGACGAGCG
GATGATCTGCACGCCGTTCTTGCGCAGTTCTTGCAGCGCCGGGACTACCCGCGACGATAC
CGAACCGTTGCCGGTACCGGCATGGATCAGCGCCTTGGCGCCGTTCTGTGCCAGGGCCTT
GTAGGCGGTGTCGGTGACGTTGCCATAGCCATACGCAATGTCTACCTGCGGCAGGCTGCT
GATCTGCTTGATATCGAACTCGGAATTGACCGTATGGCGCTTGGCCGGCAGGCGGAACCA
GTACGATTTGCCTTCCACCACCATGCCCATCGGGCCCCAGGCGCTCTTGAAGGCTTCGGT
CTTGATGTTGACCGCCTTGCTCACATCGCGGCCGGACTGGATCTCGTCGTTCATGGTCAC
CAGCACGCCCTTGCCACGCGACTGCTTGTCGCTGGCTACGGCCACGGCGTTGTACAGGTT
GAGCATGCCGTCGGCGGACATGGCGGTACCCGGACGCATCGAGCCGACCACCACGATTGG
CTTGTCGGTCTTCTCTACCAGGTTGAGGAAGAAGGCGGTTTCTTCGAGGGTATCGGTGCC
GTGGGTGATGACGATGCCGTCCACGTCCTTGCTTTCGGCCAGCTCGGCGACGCGCTTGCC
CAGCTTCAGCAGGTCGTCATTGCTGATGCTCTCGGAGGCGATCTGCATCACTTGCTCGCC
ACGTACATTGGCGATGTCGGCCAGTTCCGGCACGCCGGCGATGAGCTTGTCGACGCCCAG
CTTGGCAGCCTGGTAAGTGGCGCTGTTGGCAGCGCTGGCACCGGCGCCGGCAATGGTGCC
GCCGGTGGCGAGGATGACCACGTTGGCCAGCTTCTGTTGGGTTTCGGCTTCTTTGGCCGA
GGCGCTGGATGGCAGGATCAGCAGCAGGGCGAGTGCGCTTGGGGCGAAGGTTTTCAGTGC
GGCATTCAT

# Drug_Target_1_General_Function:
Amino acid transport and metabolism

# Drug_Target_1_General_References:
12534463	Nelson KE, Weinel C, Paulsen IT, Dodson RJ, Hilbert H, Martins dos Santos VA, Fouts DE, Gill SR, Pop M, Holmes M, Brinkac L, Beanan M, DeBoy RT, Daugherty S, Kolonay J, Madupu R, Nelson W, White O, Peterson J, Khouri H, Hance I, Chris Lee P, Holtzapple E, Scanlan D, Tran K, Moazzez A, Utterback T, Rizzo M, Lee K, Kosack D, Moestl D, Wedler H, Lauber J, Stjepandic D, Hoheisel J, Straetz M, Heim S, Kiewitz C, Eisen JA, Timmis KN, Dusterhoft A, Tummler B, Fraser CM: Complete genome sequence and comparative analysis of the metabolically versatile Pseudomonas putida KT2440. Environ Microbiol. 2002 Dec;4(12):799-808.

# Drug_Target_1_HGNC_ID:
Not Available

# Drug_Target_1_HPRD_ID:
Not Available

# Drug_Target_1_ID:
2988

# Drug_Target_1_Locus:
Not Available

# Drug_Target_1_Molecular_Weight:
38608

# Drug_Target_1_Name:
Glutaminase-asparaginase

# Drug_Target_1_Number_of_Residues:
362

# Drug_Target_1_PDB_ID:
4PGA

# Drug_Target_1_Pathway:
Not Available

# Drug_Target_1_Pfam_Domain_Function:
PF00710	Asparaginase

# Drug_Target_1_Protein_Sequence:
>Glutaminase-asparaginase precursor
MNAALKTFAPSALALLLILPSSASAKEAETQQKLANVVILATGGTIAGAGASAANSATYQ
AAKLGVDKLIAGVPELADIANVRGEQVMQIASESISNDDLLKLGKRVAELAESKDVDGIV
ITHGTDTLEETAFFLNLVEKTDKPIVVVGSMRPGTAMSADGMLNLYNAVAVASDKQSRGK
GVLVTMNDEIQSGRDVSKAVNIKTEAFKSAWGPMGMVVEGKSYWFRLPAKRHTVNSEFDI
KQISSLPQVDIAYGYGNVTDTAYKALAQNGAKALIHAGTGNGSVSSRVVPALQELRKNGV
QIIRSSHVNQGGFVLRNAEQPDDKNDWVVAHDLNPQKARILAMVAMTKTQDSKELQRIFW
EY

# Drug_Target_1_Reaction:
L-glutamine + H2O = L-glutamate + NH3

# Drug_Target_1_Signals:
1-25

# Drug_Target_1_Specific_Function:
L-glutamine + H(2)O = L-glutamate + NH(3)

# Drug_Target_1_SwissProt_ID:
Q88K39

# Drug_Target_1_SwissProt_Name:
ASPQ_PSEPK

# Drug_Target_1_Synonyms:
EC 3.5.1.38
Glutaminase-asparaginase precursor
L-ASNase/L-GLNase
L-asparagine/L- glutamine amidohydrolase

# Drug_Target_1_Theoretical_pI:
7.85

# Drug_Target_1_Transmembrane_Regions:
None

#END_DRUGCARD DB02571
